(Yicai) April 3 -- China's Center for Drug Evaluation has accepted the market application of Merck for Clesrovimab, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback